Lavender: study protocols
9 study groups say how much Lavender participants took a day. These are the doses the studies gave. They are not a recommendation.
Dose per serving from products
26 products in our catalogue print how much Lavender a serving holds.
Most common: 25 mg to 50 mg, 23% of 26 products.
| Dose per serving | Products |
|---|---|
| 5 mg or less | 2 |
| 5 mg to 10 mg | 0 |
| 10 mg to 25 mg | 5 |
| 25 mg to 50 mg | 6 |
| 50 mg to 100 mg | 5 |
| 100 mg to 250 mg | 4 |
| 250 mg to 500 mg | 1 |
| 500 mg to 1 g | 1 |
| 1 g to 2.5 g | 2 |
Dose per serving from research
9 study groups in 5 studies say how much Lavender participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 50 mg to 100 mg, 56% of 9 study groups.
| Daily dose | Study groups |
|---|---|
| 10 mg or less | 1 |
| 10 mg to 25 mg | 0 |
| 25 mg to 50 mg | 1 |
| 50 mg to 100 mg | 5 |
| 100 mg to 250 mg | 2 |
Commonly used together
None of these 9 study groups took Lavender with anything else.
9 study groups
| Study | |||
|---|---|---|---|
| Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial 2025 · Silexan · Adults of any sex with mild-to-moderate, single or recurrent major depressive disorder | 80 mg | 8 weeks | 170 |
| Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine 2014 · Silexan 80 mg/d group · Adults with generalized anxiety disorder (GAD) according to DSM-5 criteria and a Hamilton Anxiety Scale total score ≥18 points | 80 mg | 10 weeks | 135 |
| Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine 2014 · Silexan 160 mg/d group · Adults with generalized anxiety disorder (GAD) according to DSM-5 criteria and a Hamilton Anxiety Scale total score ≥18 points | 160 mg | 10 weeks | 121 |
| The effect of lavender on mood disorders associated with the use of combined oral contraceptives (COCs): a triple-blinded randomized controlled trial 2024 · LEO group · Women aged 15–49 using combined oral contraceptives, with a high negative-to-positive emotional score and without depression or a recent diagnosis of psychological health problems | 80 mg | 8 weeks | 30 |
| Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial 2010 · Silexan · Adults with anxiety disorder not otherwise specified, with HAMA total score ≥18 and PSQI total score >5 | 80 mg | 10 weeks | — |
| Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set 2017 · 10 mg/day Silexan · Adults with generalized anxiety disorder meeting DSM criteria and a Hamilton Anxiety Scale total score of at least 18 | 10 mg | 10 weeks | — |
| Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set 2017 · 40 mg/day Silexan · Adults with generalized anxiety disorder meeting DSM criteria and a Hamilton Anxiety Scale total score of at least 18 | 40 mg | 10 weeks | — |
| Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set 2017 · 80 mg/day Silexan · Adults with generalized anxiety disorder meeting DSM criteria and a Hamilton Anxiety Scale total score of at least 18 | 80 mg | 10 weeks | — |
| Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set 2017 · 160 mg/day Silexan · Adults with generalized anxiety disorder meeting DSM criteria and a Hamilton Anxiety Scale total score of at least 18 | 160 mg | 10 weeks | — |